Paracervical Vasopressin Injection Compared With Intramyometrial Vasopressin in Abdominal Myomectomy

• Status: Unknown status
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: Female

Summary

The goal of the investigators study is to evaluate the effectiveness of paracervical injection of vasopressin at the time of abdominal myomectomy to decrease blood loss. The investigators will continue to use intramyometrial vasopressin as this has previously been shown to be effective. The study will not exceed the safely documented dose of vasopressin.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University Hospitals Cleveland Medical Center
• Treatments: Arginine Vasopressin; Vasopressins

Criteria

Inclusion Criteria:

• Age 18-60 years old

• All women who are candidates for abdominal myomectomy and are willing to accept randomization

Exclusion Criteria:

• Patients unable to consent for the study

• Suspected malignancy

• History of adverse reaction or allergy to vasopressin

• Active cardiovascular or pulmonary disease that would indicate a contraindication to use of vasopressin